Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...
The videogame retailer’s shares jumped following the latest cryptic post from influential trader Keith Gill, aka “Roaring ...
What makes that call particularly surprising is that most pundits are still skeptical about Palantir. Among the 20 analysts ...
Musk reacted on his X social media platform to the ruling on Monday by Court of Chancery Judge Kathleen McCormick.
Additionally, one closely watched Wall Street analyst said that AI software stocks would be winners in 2025. As a result, ...
Analysts at Wedbush have increased the price target of Tesla's car maker to $400 while retaining the Outperform' rating. They ...
Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...
As previously reported, Wedbush downgraded Cavco Industries (CVCO) to Neutral from Outperform with an unchanged price target of $480. With Cavco shares up 49% year-to-date through December 2 and ...
Wedbush’s price target would suggest a potential upside of 3.05% from the company’s previous close. A number of other brokerages also recently issued reports on UPST.
VinFast Auto Ltd. (NASDAQ:VFS – Free Report) – Equities researchers at Wedbush raised their FY2024 EPS estimates for shares of VinFast Auto in a research note issued on Wednesday, November 27th.
(Bloomberg) — Wedbush Securities, the Los Angeles-based brokerage consistently ranked among the top firms by Nasdaq trading volume, was accused by the U.S. Securities and Exchange Commission of ...
Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after assuming coverage of the name. The firm added the company’s tau antibody for ...